Natera Funding & Investors
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
https://www.natera.com/Total Amount Raised: $1,163,150,080
Natera Funding Rounds
Post Ipo Equity
$250,000,000
Post Ipo Equity
$400,050,000
Post Ipo Equity
$5,000,000
Post Ipo Equity Investors
Matthew RabinowitzRoelof BothaPost Ipo Equity
$250,000,000
Post Ipo Equity
$104,000,000
Series F
$55,500,000
Series F Investors
Sofinnova VenturesFranklin Resources, Inc.Jennison AssociatesRA Capital ManagementHealthCor Partners ManagementOrbiMed AdvisorsSequoia CapitalIPO
Unknown
Series E
$54,600,000
Series E Investors
Harmony PartnersOrbiMed AdvisorsFounders FundLightspeed Venture PartnersClaremont Creek VenturesSequoia CapitalSeries D
$20,000,000
Series D Investors
Lightspeed Venture PartnersClaremont Creek VenturesSequoia CapitalGrant
$2,000,000
Grant Investors
National Institutes of Health (NIH)Series C
$12,000,000
Series C Investors
Sequoia CapitalSeries B
$6,000,000
Series B Investors
Claremont Creek VenturesSequoia CapitalAlafi CapitalSeries A
$4,000,000
Series A Investors
Claremont Creek VenturesSequoia Capital